Attovia Therapeutics logo

Attovia Therapeutics Funding & Investors

Fremont, CA

Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.

attovia.com

Total Amount Raised: $165,000,000

Attovia Therapeutics Funding Rounds

  • Series B

    $105,000,000

    Series B Investors

    Goldman Sachs Asset Management
    Cormorant Asset Management
    Frazier Life Sciences
    Illumina Ventures
    venBio Partners
    Logos Capital
    EcoR1 Capital
    Nextech Ventures
    Redmile Group
    Marshall Wace
  • Series A

    $60,000,000

    Series A Investors

    Frazier Life Sciences
    Illumina Ventures
    venBio Partners
Funding info provided by Diffbot.